Compositions and methods for targeted delivery to cells
US-2024390271-A1 · Nov 28, 2024 · US
US9540402B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9540402-B2 |
| Application number | US-201414584834-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 29, 2014 |
| Priority date | Jan 31, 2003 |
| Publication date | Jan 10, 2017 |
| Grant date | Jan 10, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as • methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
Opening claim text (preview).
What is claimed is: 1. A composition comprising a dehalogenase substrate of the formula R-linker-A-X, wherein R is an affinity molecule that forms a covalent bond with an acceptor molecule, A-X is a substrate for said dehalogenase, X is a halogen, and the linker is a group that separates R and A; wherein R, linker, A, and X are covalently linked. 2. The composition of claim 1 , wherein A is (CH2)n and n=4-10. 3. The composition of claim 2 , wherein A is (CH2)n and n=6-10. 4. The composition of claim 1 , wherein the linker is a branched or unbranched carbon chain comprising no more than 30 carbons. 5. The composition of claim 4 , wherein the linker comprises —C(O)NH(CH2CH2O)y, wherein y=2-8. 6. The composition of claim 1 , wherein X is Cl or Br. 7. The composition of claim 1 , wherein linker-A separates R and X by at least 11 atoms. 8. A system comprising the composition of claim 1 and the acceptor molecule. 9. The system of claim 8 , wherein the acceptor molecule is free in solution. 10. The system of claim 8 , wherein the acceptor molecule is bound to a solid support. 11. The system of claim 10 , wherein the solid support is solid support is a surface plasmon resonance chip, a magnetic particle, a membrane, glass, cellulose, self-assembled monolayers, a well of a multi-well plate, an electron conducting surface, or an agarose bead.
involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title
the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom · CPC title
with oxygen atoms in positions 1 and 3, e.g. phthalimide · CPC title
Fluorescent dyes, e.g. rhodamine · CPC title
with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.